- Home
- SYTA vs RSLS Comparison
SYTA vs RSLS Comparison
Compare SYTA & RSLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYTA
- RSLS
- Stock Information
- Founded
- SYTA N/A
- RSLS 2002
- Country
- SYTA Canada
- RSLS United States
- Employees
- SYTA N/A
- RSLS N/A
- Industry
- SYTA Telecommunications Equipment
- RSLS Medical/Dental Instruments
- Sector
- SYTA Telecommunications
- RSLS Health Care
- Exchange
- SYTA Nasdaq
- RSLS Nasdaq
- Market Cap
- SYTA 3.1M
- RSLS 3.2M
- IPO Year
- SYTA 2020
- RSLS 2007
- Fundamental
- Price
- SYTA $3.23
- RSLS $1.12
- Analyst Decision
- SYTA
- RSLS Hold
- Analyst Count
- SYTA 0
- RSLS 1
- Target Price
- SYTA N/A
- RSLS N/A
- AVG Volume (30 Days)
- SYTA 240.3K
- RSLS 2.6M
- Earning Date
- SYTA 04-07-2025
- RSLS 03-31-2025
- Dividend Yield
- SYTA N/A
- RSLS N/A
- EPS Growth
- SYTA N/A
- RSLS N/A
- EPS
- SYTA N/A
- RSLS N/A
- Revenue
- SYTA $11,988,979.00
- RSLS $8,183,000.00
- Revenue This Year
- SYTA $75.92
- RSLS $17.47
- Revenue Next Year
- SYTA $19.72
- RSLS $20.00
- P/E Ratio
- SYTA N/A
- RSLS N/A
- Revenue Growth
- SYTA 41.59
- RSLS N/A
- 52 Week Low
- SYTA $3.04
- RSLS $1.01
- 52 Week High
- SYTA $885.60
- RSLS $29.00
- Technical
- Relative Strength Index (RSI)
- SYTA 30.99
- RSLS 19.11
- Support Level
- SYTA $3.04
- RSLS $1.01
- Resistance Level
- SYTA $5.40
- RSLS $1.85
- Average True Range (ATR)
- SYTA 0.49
- RSLS 0.35
- MACD
- SYTA -0.06
- RSLS -0.18
- Stochastic Oscillator
- SYTA 8.05
- RSLS 3.99
About SYTA Siyata Mobile Inc.
Siyata Mobile Inc is engaged in the sale of vehicle mounted, cellular-based communications platforms over advanced 3G (Third generation) mobile networks and cellular booster systems. The Company develops, markets and sells a portfolio of rugged handheld Push-to-Talk over Cellular (PoC) smartphone devices. These rugged business-to-business (B2B) environments are focused on enterprise customers, first responders, construction workers, security guards, government agencies, utilities, transportation and waste management, amusement parks, and mobile workers in multiple industries. The company operates in USA, Canada, EMEA and Australia. It derives maximum revenue from USA.
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.